Riskpilot← Back to searchSign inGet full accessGloben Hjärtmottagning AB
ABActiveOrg 5591489488Arenavägen 33Medical specialists activities · NACE 8622Est. 20181 employees
Revenue 2024
SEK 2,5M
-2% vs 2023
EBITDA margin
19.1%
-30% vs 2023
Equity ratio
90.4%
Financial strength
Net profit 2024
SEK 171K
-49% vs 2023
| Revenue | SEK 2,5M | -2% |
| EBITDA | SEK 479K | -30% |
| Net profit | SEK 171K | -49% |
| Total assets | SEK 1,4M | -8% |
| Equity | SEK 1,3M | +16% |
| Employees | 1 | — |
Legal name
Globen Hjärtmottagning AB
Org number
5591489488
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
12 februari 2018
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva kardiovaskulär läkarmottagning, klinisk fysiologiskt laboratorium och kliniska läkemedelsprövningar samt därmed förenlig verksamhet.
Address
Arenavägen 33
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 440 | 2 164 | 2 362 | 2 568 | 2 507 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 396 | 399 | 746 | 685 | 479 |
| Depreciation & amort. | −260 | −260 | −260 | −260 | −260 |
| EBIT | 136 | 139 | 486 | 425 | 219 |
| Net financials | — | — | — | — | −2 |
| Profit before tax | 136 | 139 | 485 | 425 | 216 |
| Tax | −29 | −29 | −100 | −87 | −45 |
| Net profit | 107 | 110 | 385 | 338 | 171 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2 315 | 2 016 | 1 905 | 1 510 | 1 388 |
| Equity | 250 | 360 | 746 | 1 083 | 1 255 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 2 064 | 1 656 | 1 159 | 427 | 133 |
| Total debt | 2 064 | 1 656 | 1 159 | 427 | 133 |
EBITDA margin
19.1%
This company
15.8%
Market median
+21% vs market
20202024
Equity ratio
90.4%
This company
38.2%
Market median
+137% vs market
20202024
Return on equity
13.6%
This company
18.4%
Market median
+26% vs market
20202024
Net profit margin
6.8%
This company
8.1%
Market median
-16% vs market
20202024
Asset turnover
1.81×
This company
1.12×
Market median
+62% vs market
20202024
Debt / equity
0.11×
This company
0.62×
Market median
+82% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JL Audit | Audit | 2024 |
| Former (1) | ||
CÅ Audit | Audit | 2022 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Globen Hjärtmottagning AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Curt Åke Johansson | Audit | 0 companies |
| Joakim Lindberg | Audit | 0 companies |
| Anna Gunilla Gabriel | Deputy Board Member | 0 companies |
| Amon Gabriel | Board of Directors | 0 companies |